Belantamab Mafodotin for Multiple Myeloma Treatment Program
Supply of Belantamab Mafodotin for the implementation of drug program B.54 for the treatment of patients with multiple myeloma.
CONTRACTING AUTHORITY
Name
UNIWERSYTECKI SZPITAL KLINICZNY W POZNANIU
City
Poznań
Country
PL
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
31 days remaining(LOT-0001)
Published